Fig. 6From: Association between body mass index and survival outcomes for cancer patients treated with immune checkpoint inhibitors: a systematic review and meta-analysisa Pooled analysis showing incidence difference of immune-related adverse effects between overweight cancer patients and normal patients receiving immune checkpoint inhibitors treatment; b Pooled analysis showing incidence difference of immune-related adverse effects between obese cancer patients and normal patients receiving immune checkpoint inhibitors treatmentBack to article page